A systematic review and meta-analysis investigating gender differences in in-hospital, short-term and long-term outcomes among patients who underwent primary PCI.

IF 1.3 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Minerva cardiology and angiology Pub Date : 2025-12-01 Epub Date: 2025-02-05 DOI:10.23736/S2724-5683.24.06670-5
Iva Patel, Pooja Vyas, Anand Shukla, Pratik Shah, Deepanshu Assudani, Khushboo Chauhan
{"title":"A systematic review and meta-analysis investigating gender differences in in-hospital, short-term and long-term outcomes among patients who underwent primary PCI.","authors":"Iva Patel, Pooja Vyas, Anand Shukla, Pratik Shah, Deepanshu Assudani, Khushboo Chauhan","doi":"10.23736/S2724-5683.24.06670-5","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>To assess how gender disparities impact major adverse cardiovascular events during hospitalization, as well as in the short and long term, among patients with ST-elevation myocardial infarction who undergo primary PCI.</p><p><strong>Evidence acquisition: </strong>PubMed, Scopus and Cochrane database were searched for relevant studies. Studies were included if all comers with STEMI, reported gender specific patient characteristics, treatments and outcomes. Odds ratio and 95% confidence interval were calculated using random effect model.</p><p><strong>Evidence synthesis: </strong>A total of 23 studies were included for the pooled meta-analysis. Average age of female at presentation was 68.61±3.91 years while in male was 60.83±2.48 years. In unadjusted analysis, female patients were at higher risk for mortality (OR=1.98, 95% CI: 1.71-2.30, P<0.0001, I<sup>2</sup>=35%) at hospitalization, (OR=2.25, 95% CI=1.75-2.88, P≤0.00001) at short term and (OR=1.76, 95% CI: 1.41-2.21, P<0.000, I<sup>2</sup>=68%) at long term. The adjusted analysis of major adverse cardiovascular events for short term (OR=1.09, 95% CI: 0.91-1.31, P=0.37, I<sup>2</sup>=76%) and long term (OR=1.05, 95% CI: 0.98-1.12, P=0.17, I<sup>2</sup>=37%) were not found significant between both genders. However, it remained significant during hospitalization (OR=1.12, 95% CI: 1.03-1.22, I<sup>2</sup>=15%, Tau<sup>2</sup>=0.00).</p><p><strong>Conclusions: </strong>The findings of this comprehensive meta-analysis indicate higher major adverse cardiac events among women with STEMI who underwent PPCI. After adjusting for comorbidities, the difference between women and men showed insignificant at short term and long term but remained significant at in-hospital. Female patients exhibited a higher prevalence of cardiovascular risk factors than men. Implementing intensive cardiovascular risk reduction strategies in women may offer a pathway to address this gender disparity.</p>","PeriodicalId":18668,"journal":{"name":"Minerva cardiology and angiology","volume":" ","pages":"787-796"},"PeriodicalIF":1.3000,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Minerva cardiology and angiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.23736/S2724-5683.24.06670-5","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/5 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: To assess how gender disparities impact major adverse cardiovascular events during hospitalization, as well as in the short and long term, among patients with ST-elevation myocardial infarction who undergo primary PCI.

Evidence acquisition: PubMed, Scopus and Cochrane database were searched for relevant studies. Studies were included if all comers with STEMI, reported gender specific patient characteristics, treatments and outcomes. Odds ratio and 95% confidence interval were calculated using random effect model.

Evidence synthesis: A total of 23 studies were included for the pooled meta-analysis. Average age of female at presentation was 68.61±3.91 years while in male was 60.83±2.48 years. In unadjusted analysis, female patients were at higher risk for mortality (OR=1.98, 95% CI: 1.71-2.30, P<0.0001, I2=35%) at hospitalization, (OR=2.25, 95% CI=1.75-2.88, P≤0.00001) at short term and (OR=1.76, 95% CI: 1.41-2.21, P<0.000, I2=68%) at long term. The adjusted analysis of major adverse cardiovascular events for short term (OR=1.09, 95% CI: 0.91-1.31, P=0.37, I2=76%) and long term (OR=1.05, 95% CI: 0.98-1.12, P=0.17, I2=37%) were not found significant between both genders. However, it remained significant during hospitalization (OR=1.12, 95% CI: 1.03-1.22, I2=15%, Tau2=0.00).

Conclusions: The findings of this comprehensive meta-analysis indicate higher major adverse cardiac events among women with STEMI who underwent PPCI. After adjusting for comorbidities, the difference between women and men showed insignificant at short term and long term but remained significant at in-hospital. Female patients exhibited a higher prevalence of cardiovascular risk factors than men. Implementing intensive cardiovascular risk reduction strategies in women may offer a pathway to address this gender disparity.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
一项系统回顾和荟萃分析,调查了接受初级PCI患者住院、短期和长期结局的性别差异。
目的:评估性别差异如何影响st段抬高型心肌梗死接受初级PCI的患者住院期间以及短期和长期的主要不良心血管事件。证据获取:检索PubMed、Scopus和Cochrane数据库相关研究。如果所有STEMI患者报告了特定性别的患者特征、治疗方法和结果,则纳入研究。采用随机效应模型计算优势比和95%置信区间。证据综合:共有23项研究被纳入合并荟萃分析。女性平均年龄68.61±3.91岁,男性平均年龄60.83±2.48岁。在未调整分析中,女性患者住院时的死亡率(OR=1.98, 95% CI: 1.71-2.30, P2=35%)、短期死亡率(OR=2.25, 95% CI=1.75-2.88, P≤0.00001)和长期死亡率(OR=1.76, 95% CI: 1.41-2.21, P2=68%)较高。短期(OR=1.09, 95% CI: 0.91-1.31, P=0.37, I2=76%)和长期(OR=1.05, 95% CI: 0.98-1.12, P=0.17, I2=37%)的主要心血管不良事件调整分析在两性间无显著差异。然而,在住院期间仍具有显著性(OR=1.12, 95% CI: 1.03-1.22, I2=15%, Tau2=0.00)。结论:这项综合荟萃分析的结果表明,STEMI患者接受PPCI的主要不良心脏事件发生率更高。在调整合并症后,男女之间的差异在短期和长期均不显著,但在住院时仍显着。女性患者心血管危险因素的患病率高于男性。在妇女中实施强化心血管风险降低策略可能为解决这一性别差异提供一条途径。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Minerva cardiology and angiology
Minerva cardiology and angiology CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
2.60
自引率
18.80%
发文量
118
期刊最新文献
Presepsin as a biomarker of coronary artery disease in type 2 diabetes along the immune-inflammatory continuum. Bridging cardiology and neurorehabilitation: toward integrated recovery after acute and chronic cardiac events. Use of vericiguat in a patient with heart failure with reduced ejection fraction and transthyretin cardiac amyloidosis: a helpful therapeutic opportunity. A new tool for risk stratification in transcatheter aortic valve intervention. The future of coronary artery bypass grafting.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1